Cernostics Revenue and Competitors

Location

N/A

Total Funding

AI

Industry

Estimated Revenue & Valuation

  • Cernostics's estimated annual revenue is currently $140k per year.(i)
  • Cernostics's estimated revenue per employee is $70,000

Employee Data

  • Cernostics has 2 Employees.(i)
  • Cernostics grew their employee count by -33% last year.

Cernostics's People

NameTitleEmail/Phone
1
VP MarketingReveal Email/Phone
2
Associate ScientistReveal Email/Phone
3
Sales RepresentativeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.5M7-36%N/AN/A
#2
$0.8M10-9%N/AN/A
#3
$5.6M50-19%N/AN/A
#4
$1.6M19-5%N/AN/A
#5
$0.6M9-25%N/AN/A
#6
$0.5M7-36%N/AN/A
#7
$1.3M16-24%N/AN/A
#8
$0.6M9-55%N/AN/A
#9
$6.9M5510%N/AN/A
#10
$0.1M2-33%N/AN/A
Add Company

What Is Cernostics?

Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types. Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Learn more about our technology platform [www.cernostics.com] and how it will change the future of cancer diagnostics.

keywords:N/A

N/A

Total Funding

2

Number of Employees

$140k

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cernostics News

2022-04-19 - Faros Properties inks Castle Biosciences to take more than ...

It's space that will combine wet lab space and office, and will enable Castle to expand the local operations of Cernostics Inc. a startup...

2022-04-06 - Castle Biosciences expanding sales efforts, lab space after ...

The dermatology business has an estimated addressable market of nearly $2 billion, and the TissueCypher test from the Cernostics acquisition...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M2-33%N/A
#2
N/A2-94%N/A
#3
$0.1M20%N/A
#4
$0.2M2-33%N/A
#5
$7.5M2-33%N/A